LON:RWS - RWS Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: GBX 720.25
Forecasted Upside: 12.80 %
Number of Analysts: 4
Breakdown:
0 Sell Ratings
0 Hold Ratings
4 Buy Ratings
0 Strong Buy Ratings

GBX 638.50 As of 05/14/2021 01:00 AM ET

▲ +2.5 (0.39%)

1 month | 3 months | 12 months

Get New RWS Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for RWS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RWS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

GBX 720.25

▲ +12.80% Upside Potential

This price target is based on 4 analysts offering 12 month price targets for RWS in the last 3 months. The average price target is GBX 720.25, with a high forecast of GBX 820 and a low forecast of GBX 610. The average price target represents a 12.80% upside from the last price of GBX 638.50.

Buy

The current consensus among 4 contributing investment analysts is to buy stock in RWS. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

11/22/2019

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/20/2020

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/20/2020

0 strong buy ratings
3 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

8/18/2020

0 strong buy ratings
2 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

11/16/2020

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

2/14/2021

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/15/2021

0 strong buy ratings
4 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

5/15/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Details
4/22/2021	Berenberg Bank	Reiterated Rating	Buy	GBX 820	i
2/1/2021	Canaccord Genuity	Initiated Coverage	Buy	GBX 690	i
1/19/2021	Jefferies Financial Group	Reiterated Rating	Buy	GBX 761	i
9/1/2020	Barclays	Reiterated Rating	Overweight	GBX 610	i
7/3/2020	Berenberg Bank	Reiterated Rating	Buy		i
6/10/2020	Barclays	Lower Price Target	Overweight	GBX 630 ➝ GBX 610	i
6/9/2020	Berenberg Bank	Boost Price Target	Buy	GBX 650 ➝ GBX 700	i
4/24/2020	HSBC	Lower Price Target	Hold	GBX 600 ➝ GBX 530	i
1/13/2020	HSBC	Reiterated Rating	Hold		i
12/18/2019	Barclays	Boost Price Target	Overweight	GBX 615 ➝ GBX 630	i
12/10/2019	Berenberg Bank	Boost Price Target	Buy	GBX 670 ➝ GBX 740	i
10/16/2019	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Overweight	GBX 615	i
10/16/2019	Barclays	Boost Price Target	Overweight	GBX 610 ➝ GBX 615	i
10/4/2019	Berenberg Bank	Reiterated Rating	Buy		i
6/12/2019	Barclays	Boost Price Target	Overweight	GBX 560 ➝ GBX 610	i
6/11/2019	Berenberg Bank	Boost Price Target	Buy	GBX 615 ➝ GBX 670	i
6/6/2019	Numis Securities	Downgrade	Add	GBX 450 ➝ GBX 600	i
4/18/2019	Berenberg Bank	Boost Price Target	Buy	GBX 530 ➝ GBX 615	i
1/18/2019	Barclays	Initiated Coverage	Overweight	GBX 560	i
10/10/2018	Numis Securities	Downgrade	Add	GBX 510	i
6/22/2018	Berenberg Bank	Reiterated Rating	Buy	GBX 530	i
6/7/2018	Shore Capital	Reiterated Rating	Hold		i
6/7/2018	Numis Securities	Upgrade	Buy	GBX 490 ➝ GBX 450	i
4/24/2018	Numis Securities	Reiterated Rating	Add	GBX 490	i
4/24/2018	Shore Capital	Reiterated Rating	Hold	GBX 459	i
3/28/2018	Berenberg Bank	Reiterated Rating	Buy	GBX 530	i
2/13/2018	Numis Securities	Reiterated Rating	Add	GBX 490	i
12/7/2017	Berenberg Bank	Reiterated Rating	Buy	GBX 530	i
12/6/2017	Numis Securities	Upgrade	Add	GBX 490	i
12/6/2017	Shore Capital	Reiterated Rating	Hold		i
11/29/2017	Berenberg Bank	Initiated Coverage	Buy	GBX 530	i
10/19/2017	Numis Securities	Boost Price Target	Hold	GBX 430 ➝ GBX 490	i
10/18/2017	Shore Capital	Reiterated Rating	Hold		i
10/8/2017	Numis Securities	Boost Price Target	Hold	GBX 375 ➝ GBX 430	i
10/2/2017	Numis Securities	Reiterated Rating	Hold	GBX 375	i
10/2/2017	Shore Capital	Reiterated Rating	Hold		i
8/10/2017	Shore Capital	Reiterated Rating	Hold		i
8/3/2017	Shore Capital	Downgrade	Hold		i
7/6/2017	Citigroup	Initiated Coverage	Neutral	GBX 395	i
6/20/2017	Shore Capital	Reiterated Rating	Buy		i
4/12/2017	Numis Securities	Reiterated Rating	Add	GBX 375	i
4/12/2017	Shore Capital	Reiterated Rating	Buy		i
2/14/2017	Numis Securities	Reiterated Rating	Add	GBX 375	i
2/14/2017	Shore Capital	Reiterated Rating	Buy		i
12/6/2016	Numis Securities	Reiterated Rating	Add	GBX 335	i
10/11/2016	Numis Securities	Boost Price Target	Add	GBX 255 ➝ GBX 295	i
6/7/2016	Numis Securities	Reiterated Rating	Add	GBX 255	i

(Data available from 5/16/2016 forward)

RWS Holdings plc engages in the translation, intellectual property (IP) support, life sciences language, and localization businesses. The company operates through IP Services, Life Sciences, and Moravia segments. The IP Services segment provides patent translation and filing solutions, as well as IP search services. The Life Sciences segment offers a full suite of language services, including language solutions for clinical trial management; linguistic validation of clinical outcomes assessments; and regulatory affairs expertise, medical device documentation, and marketing and communications services, as well as e-learning and training programs for the life sciences industry. The Moravia segment provide localized products and content to consumers. It serves automotive, energy, retail and e-commerce, legal, travel and hospitality, banking and finance, industrial and manufacturing, life sciences, technology, chemical, media and entertainment, and telecommunication sectors. The company primarily operates in the United Kingdom, the United States, Continental Europe, China, Japan, India, Thailand, Argentina, Australia, Columbia, and Canada. RWS Holdings plc was founded in 1958 and is headquartered in Chalfont St Peter, the United Kingdom.

Today's Range

Now: GBX 638.50

632

659

50 Day Range

MA: GBX 661.92

609

696.50

52 Week Range

Now: GBX 638.50

6.22

767

Volume

234,150 shs

Average Volume

1,155,821 shs

Market Capitalization

£2.49 billion

P/E Ratio

37.78

Dividend Yield

1.41%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of RWS?

The following Wall Street analysts have issued research reports on RWS in the last twelve months: Barclays PLC, Berenberg Bank, Canaccord Genuity, and Jefferies Financial Group Inc..
View the latest analyst ratings for RWS.

What is the current price target for RWS?

4 Wall Street analysts have set twelve-month price targets for RWS in the last year. Their average twelve-month price target is GBX 720.25, suggesting a possible upside of 12.8%. Berenberg Bank has the highest price target set, predicting RWS will reach GBX 820 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of GBX 610 for RWS in the next year.
View the latest price targets for RWS.

What is the current consensus analyst rating for RWS?

RWS currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RWS will outperform the market and that investors should add to their positions of RWS.
View the latest ratings for RWS.

What other companies compete with RWS?

Other companies that are similar to RWS include Intertek Group, Rentokil Initial, Ritchie Bros. Auctioneers, IWG, HomeServe, Keywords Studios, BCA Marketplace, GlobalData, Serco Group, GDI Integrated Facility Services, Energy Fuels, Smart Metering Systems, Mitie Group, Johnson Service Group and Capita.

How do I contact RWS's investor relations team?

RWS's physical mailing address is Europa House Chiltern Park, Chiltern Hill, GERRARDS CROSS, SL9 9FG, United Kingdom. The company's listed phone number is +44-1753-480200. The official website for RWS is www.rws.com.